Petros Pharmaceuticals Inc (PTPI)
0.692
-0.02
(-2.99%)
USD |
NASDAQ |
May 06, 16:00
0.692
0.00 (0.00%)
After-Hours: 20:00
Petros Pharmaceuticals Total Long Term Debt (Quarterly): 8.014M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.014M |
| September 30, 2023 | 8.388M |
| June 30, 2023 | 8.757M |
| March 31, 2023 | 9.120M |
| December 31, 2022 | 9.478M |
| September 30, 2022 | 9.663M |
| June 30, 2022 | 10.02M |
| March 31, 2022 | 10.20M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 1.741M |
| June 30, 2021 | 3.425M |
| March 31, 2021 | 5.061M |
| December 31, 2020 | 7.175M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
10.20M
Maximum
Mar 2022
5.690M
Average
7.594M
Median
Total Long Term Debt (Quarterly) Benchmarks
| Avalo Therapeutics Inc | 0.00 |
| Imunon Inc | -- |
| iBio Inc | -- |
| Oramed Pharmaceuticals Inc | -- |
| Ocugen Inc | 2.80M |